Ironwood Pharmaceuticals Inc’s recent filing unveils that its Officer MCCOURT Thomas A acquired Company’s shares for reported $8650.0 on May 19 ’25. In the deal valued at $0.59 per share,14,661 shares were bought.
Then, Gaskins Tammi L bought 2,814 shares, generating $1,660 in total proceeds.
Before that, MCCOURT Thomas A sold 139,064 shares. Ironwood Pharmaceuticals Inc shares valued at $244,753 were divested by the Chief Executive Officer at a price of $1.76 per share. As a result of the transaction, MCCOURT Thomas A now holds 1,160,634 shares, worth roughly $0.71 million.
Wells Fargo downgraded its Ironwood Pharmaceuticals Inc [IRWD] rating to an Equal weight from a an Overweight in a research note published recently. A number of analysts have revised their coverage, including Jefferies’s analysts, who decreased its forecast for the stock in mid April from “a Buy” to “a Hold”. Citizens JMP also remained covering IRWD and has decreased its forecast on April 14, 2025 with a “Mkt perform” recommendation from previously “Mkt outperform” rating. Leerink Partners started covering the stock on September 09, 2024. It rated IRWD as “a Market perform”.
Price Performance Review of IRWD
On Monday, Ironwood Pharmaceuticals Inc [NASDAQ:IRWD] saw its stock jump 7.35% to $0.61. Over the last five days, the stock has lost -16.61%. Ironwood Pharmaceuticals Inc shares have fallen nearly -86.19% since the year began. Nevertheless, the stocks have fallen -90.67% over the past one year.
How much short interest is there in Ironwood Pharmaceuticals Inc?
A steep rise in short interest was recorded in Ironwood Pharmaceuticals Inc stocks on 2025-04-30, dropping by -2.45 million shares to a total of 8.8 million shares. Yahoo Finance data shows the prior-month short interest on 2025-03-31 was 11.25 million shares. There was a decline of -27.87%, which implies that there is a negative sentiment for the stock.
